google-site-verification: googlec7193c3de77668c9.html
Wednesday , October 28 2026

Melanoma vaccine reduces death or cancer recurrence by 42%

[
In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each patient’s own tumor, to pembrolizumab immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%.


Source link

Advertisements

See also  Ultrasensitive test detects biomarkers for specific form of dementia

Check Also

Autistic women experience more severe menopausal symptoms, study confirms

[ A new study by researchers at Bournemouth University has shown that autistic people consistently …

Autistic women experience more severe menopausal symptoms, study confirms

[ Credit: Marcus Aurelius from Pexels A new study by researchers at Bournemouth University has …

How socioeconomic factors affect outcomes in this deadly cancer

[ Black women diagnosed with hormone receptor–positive (HR+) breast cancer experience significantly worse outcomes than …

Leave a Reply

Available for Amazon Prime